Enliven Therapeutics Chief Scientific Officer Sells ELVN 20K Shares Worth Over $500k
Key PointsEnliven Therapeutics' Chief Scientific Officer sold 20,000 indirect shares for a total of approximately $535,100 on Jan. 20, 2026, at a weighted average price of around $26.75 per share...
Nasdaq News: Markets·15d ago